A model system for activation-induced alternative splicing of CD45 pre- mRNA in T cells implicates protein kinase C and Ras

Molecular and Cellular Biology

Volumn 20, Issue 1, 2000, Pages 70-80

  Lynch, Kristen W ^a   Weiss, Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CD45 ANTIGEN; CYCLOHEXIMIDE; MESSENGER RNA; PROTEIN KINASE C; RAS PROTEIN;

ARTICLE; CELL STIMULATION; ENZYME ACTIVATION; EXON; HUMAN; HUMAN CELL; MODEL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SPLICING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0033986766     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.1.70-80.2000     Document Type: Article

References (68)

1. Adams, M. D., D. Z. Rudner, and D. C. Rio. 1996. Biochemistry and regulation of pre-mRNA splicing. Curr. Opin. Cell Biol. 8:331-339.
2. Akbar, A. N., L. Terry, A. Timms, P. C. L. Beverley, and G. Janossy. 1988. Loss of CD45R and gain of UCHLI reactivity is a feature of primed T cells. J. Immunol. 140:2171-2178.
3. Bell, E. B., and S. M. Sparshott. 1990. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 348:163-166.
4. Berget, S. M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411-2414.
5. Birkeland, M. L., P. Johnson, I. S. Trowbridge, and E. Pure. 1989. Changes in CD45 isoform expression accompany antigen-induced murine T cell activation. Proc. Natl. Acad. Sci. USA 86:6734-6738.
6. Black, D. L. 1995. Finding splice sites within a wilderness of RNA. RNA 1: 763-771.
7. + thymocytes, and in B cell maturation. J. Exp. Med. 183:1707-1718.
8. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259-274.
9. Castagna, M., Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa, and Y. Nishizuka. 1982. Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol ester. J. Biol. Chem. 257:7847-7851.
10. Chulfant, C. E., J. E. Watson, L. D. Bisnauth, J. B. Kang, N. Patel, L. M. Obeid, D. C. Eichler, and D. R. Cooper. 1998. Insulin regulates protein kinase CbII expression through enhanced exon inclusion in L6 skeletal muscle cells. J. Biol. Chem. 273:910-916.
11. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63: 1045-1083.
12. D'Ambrosio, D., D. A. Cantrell, L. Frati, A. Santoni, and R. Testi. 1994. Involvement of p21ras activation in T cell CD69 expression. Eur. J. Immunol. 24:616-620.
13. Deans, J. P., H. M. Serra, J. Shaw, Y. J. Shen, R. M. Torres, and L. Pilarski. 1992. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J. Immunol. 148:1898-1905.
14. Desai, D. M., J. Sap, J. Schlessinger, and A. Weiss. 1993. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 73:541-554.
15. Downward, J., J. D. Graves, P. H. Warne, S. Rayter, and D. A. Cantrell. 1990. Stimulation of p21ras upon T-cell activation Nature 346:719-723.
16. Fu, X.-D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680.
17. Grabowski, P. J. 1998. Splicing regulation in neurons: tinkering with cell-specific control. Cell 92:709-712.
18. Hertel, K. J., K. W. Lynch, and T. Maniatis. 1997. Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9: 350-357.
19. Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genes Dev. 7:75-79.
20. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai, A. Wakenham, E. Timms, K. Pfeffer, P. S. Ohashi, and M. L. Thomas. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice. Cell 74:143-156.
21. Konig, H., H. Ponta, and P. Herrlich. 1998. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 17:2904-2913.
22. Koretzky, G. A., J. Picus, M. L. Thomas, and A. Weiss. 1990. Tyrosine phosphatase CD45 is essential for coupling T cell antigen receptor to the phosphatidylinositol pathway. Nature 346:66-68.
23. Koretzky, G., J. Picus, T. Schultz, and A. Weiss. 1991. Tyrosine phosphatase CD45 is required for both T cell antigen receptor and CD2 mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl. Acad. Sci. USA 88:2037-2041.
24. Koretzky, G. A., M. A. Kohmetscher, T. Kadlecek, and A. Weiss. 1992. Restoration of T cell receptor mediated signal transduction by transfection of CD45 cDNA into a CD45-deficient variant of the Jurkat T cell line. J. Immunol. 149:1138-1142.
25. Leevers, S. J., and C. J. Marshall. 1992. Activation of extracellular signal-regulated kinase, Erk2, by p21ras oncoprotein. EMBO J. 11:569-574.
26. Leitenberg, D., Y. Boulin, D. D. Lu, and K. Bottomly. 1999. Biochemical association of CD45 with the T cell receptor complex: regulation by Cd45 isoform and during T cell activation. Immunity 10:701-711.
27. Leitenberg, D., T. J. Novak, D. Farber, B. R. Smith, and K. Bottomly. 1996. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 183:249-259.
28. Lemaire, R., A. Winne, M. Sarkissian, and R. Lafyatis. 1999. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur. J. Immunol. 29:823-837.
29. Lowin-Kropf, B., V. S. Shapiro, and A. Weiss. 1998. Cytoskeletal polarization of T cells is regulated hy an immunoreceptor tyrosine-based activation motif-dependent mechanism. J. Cell Biol. 140:861-871.
30. Lui, C., J. Cheng, and J. D. Mountz. 1995. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 310:957-963.
31. Majeti, R., A. M. Bilwes, J. P. Noel, T. Hunter, and A. Weiss. 1998. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279:88-91.
32. Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1569-1579.
33. McCall, M. N., D. M. Shotton, and A. N. Barclay. 1992. Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-Cd45R monoclonal antibodies. Immunology 76:310-317.
34. McFarland, E. D., T. R. Hurley, J. T. Pingel, B. M. Sefton, A. Shaw, and M. L. Thomas. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA 90:1402-1406.
35. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
36. Ostergaard, H. L., D. A. Shackelford, T. R. Hurley, P. Johnson, R. Hyman, B. M. Sefton, and I. S. Trowbridge. 1989. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc. Natl. Acad. Sci. USA 86:8959-8963.
37. lck. J. Exp. Med. 172:347-350.
38. Ratech, H., S. Denning, and R. E. Kaufman. 1997. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans. Cell. Immunol. 177:109-118.
39. Rothstein, D. M., H. Saito, M. Streuli, S. F. Schlossman, and C. Morimoto. 1992. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. J. Biol. Chem. 267:7139-7147.
40. Rothstein, D. M., A. Yamada, S. F. Schlossman, and C. Morimoto. 1991. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line. J. Immunol. 146:1175-1183.
41. Saga, Y., K. Furukawa, P. Rogers, J. S. Tung, D. Parker, and E. A. Boyse. 1990. Further data on the selective expression of Ly-5 isoform. Immunogenetics 31:296-306.
42. Saga, Y., J. S. Lee, C. Saraiya, and E. A. Boyse. 1990. Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein. Proc. Natl. Acad. Sci. USA 87:3728-3732.
43. Sarkissian, M., A. Winne, and R. Lafyatis. 1996. The mammalian homolog of suppressor-of-white-apricot regulates alternative mRNA splicing of CD45 exon 4 and fibronectin IIICS. J. Biol. Chem. 271:31106-31114.
44. Satoh, T., M. Nakafuku, and Y. Kaziro. 1992. Function of Ras as a molecular switch in signal transduction. J. Biol. Chem. 267:24149-24152.
45. Schwinzer, R., B. Schraven, U. Kyas, S. C. Meuer, and K. Wonigeit. 1992. Phenotypical and biochemical characterization of a variant CD45R expression pattern in human leukocytes. Eur. J. Immunol. 22:1095-1098.
46. Screaton, G. R., J. K. Caceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and A. R. Krainer. 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336-4349.
47. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94:4615-4619.
48. Lck Y505F mutation in CD45-deticient mice rescues thymocyte development. Mol. Cell. Biol. 19:4200-4208.
49. Shapiro, V. S., M. N. Mollenauer, W. C. Greene, and A. Weiss. 1996 c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1. J. Exp. Med. 184:1663-1669.
50. Sieh, M., J. B. Bolen, and A. Weiss. 1993. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J. 12:315-322.
51. Smith, M. A., G. R. Fanger, L. T. O'Connor, P. Bridle, and R. A. Maue. 1997. Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by Ras-dependent actions of nerve growth factor. J. Biol. Chem. 272:15675-15681.
52. Stone, J. D., L. A. Conroy, K. F. Byth, R. A. Hederer, S. Howlett, Y. Takemoto, N. Holmes, and D. R. Alexander. 1997. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-ζ, and ZAP-70. J. Immunol. 158:5773-5782.
53. Streuli, M., L. R. Hall, Y. Saga, S. F. Schlossman, and H. Saito. 1987. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166:1548-1566.
54. Streuli, M., and H. Saito. 1989. Regulation of tissue-specific alternative splicing: exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA. EMBO J. 8:787-796.
55. Strober, W., M. E. Kanof, and P. D. Smith. 1991. Preparation of human mononuclear cell populations and subpopulations, p. 7.1.1-7.4.5. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology, vol. 1. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
56. Thude, H., J. Hundrieser, K. Wonigeit, and R. Schwinzer. 1995. A point mutation in the human CD45 gene associated with defective splicing of exon A. Eur. J. Immunol. 25:2101-2106.
57. Trowbridge, I. S. 1991. CD45: a prototype for transmembrane protein tyrosine phosphatases. J. Biol. Chem. 266:23517-23520.
58. Trowbridge, I. S., and M. L. Thomas. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116.
59. Tsai, A. Y. M., M. Streuli, and H. Saito. 1989. Integrity of the exon 6 sequence is essential for tissue-specific alternative splicing of human leukocyte common antigen pre-mRNA. Mol. Cell. Biol. 9:4550-4555.
60. Wang, J., and J. L. Manley. 1997. Regulation of pre-mRNA splicing in metazoa. Curr. Opin. Genet. Dev. 7:205-211.
61. Wang, J., L. Shin, H. Najafi, J. Kolberg, F. M. Matschinsky, M. Urdea, and M. German. 1997. Regulation of insulin preRNA splicing by glucose. Proc. Natl. Acad. Sci. USA 94:4360-4365.
62. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
63. Wiskocil, R., A. Weiss, J. Imboden, R. Kamin-Lewis, and J. Stobo. 1985. Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes. J. Immunol. 134:1599-1603.
64. vav activity. Mol. Cell. Biol. 15:4337-4346.
65. Xie, J., and D. P. McCobb. 1998. Control of alternative splicing of potassium channels by stress hormones. Science 280:443-446.
66. Yablonski, D., L. P. Kane, D. Qian, and A. Weiss. 1998. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK. EMBO J. 17:5647-5657.
67. Yamada, A., M. Streuli, H. Saito, D. M. Rothstein, S. F. Schlossman, and C. Morimoto. 1990. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells. Eur. J. Immunol. 20:1655-1660.
68. Zilch, C. F., A. M. Walker, M. Timon, L. K. Goff, D. L. Wallace, and P. C. L. Beverley. 1998. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Eur. J. Immunol. 28:22-29.